ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Registrieren

Bereits Mitglied? Einloggen

Pepperstone

Jetzt Handeln

Pepperstone
Marktdaten
News
Werkzeuge
Märkte
Entdecken

Hot Features

Follow Feed

Vernetzen Sie sich mit Händlern und Investoren in unserer Follow-Feed-Community.

Optionen-Flow

Erkunden Sie umfassende Optionsdaten und nutzen Sie erweiterte Filter mit Options Flow.

Watchlist

Organisieren und überwachen Sie Ihre Aktien- und Vermögensbeobachtungsliste mit dem Monitor.
Anmelden Premium IconPremium Help Menu
DAX
19.984,32
0,74%
S&P 500
5.953,76
-1,39%
Dow Jones
42.892,18
-1,00%
Euro vs US Dollar
1,04262
0,04%
Bitcoin
94.492,02
-1,25%
Pepperstone
Advertisement
Registration Strip Icon for discussion Registrieren Sie sich, um in unseren aktiven Foren mit gleichgesinnten Anlegern zu diskutieren.
Registrieren
  1. Startseite
  2. Investieren
  3. Aktien
  4. USA
  5. NASDAQ

  6. Legend Biotech Corporation (LEGN) Börsenkurse

Legend Biotech Corporation

Legend Biotech Corporation (LEGN)

NASDAQ
32,54
-0,24
( -0,73% )
Aktualisiert: 19:17:43
Verzögert um 15 Minuten

Echtzeit-Diskussionen und Handelsideen: Handeln Sie mit Zuversicht mit unserer leistungsstarken Plattform.

Premium

Wichtige Statistiken und Details

Current Price
32,54
Gebot
32,49
Fragen
32,57
Volumen
317.656
32,22 Tagesbereich 33,31
0,00 52-Wochen-Bereich 0,00
Marktkapitalisierung
5,919B
Handelsende
32,78
Handelsbeginn
32,65
Letzte Trade
3
@
32.51
Letzter Handelszeitpunkt
19:18:42
Finanzvolumen
US$ 10.298.577
VWAP
32,4205
Durchschnittliches Volumen (3 Mio.)
-
Ausgegebene Aktien
181.911.035
Dividendenrendite
-
Kurs-Gewinn-Verhältnis
0,00
Gewinn pro Aktie (EPS)
-
Erlöse
285,14M
Nettogewinn
-518,25M

Über Legend Biotech Corporation

Legend Biotech Corp is a clinical-stage biopharmaceutical company. It is engaged in the discovery and development of novel cell therapies for oncology and other indications. The firm's lead product candidate, LCAR-B38M/JNJ-4528, is a chimeric antigen receptor, or CAR, T cell therapy is for the treat... Legend Biotech Corp is a clinical-stage biopharmaceutical company. It is engaged in the discovery and development of novel cell therapies for oncology and other indications. The firm's lead product candidate, LCAR-B38M/JNJ-4528, is a chimeric antigen receptor, or CAR, T cell therapy is for the treatment of multiple myeloma. Geographically, the company generates a majority of its revenue from North America. Mehr anzeigen

Sektor
Pharmaceutical Preparations
Branche
Pharmaceutical Preparations
Website
www.legendbiotech.com
Hauptsitz
Grand Cayman, Cym
Gegründet
-
Legend Biotech Corporation is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker LEGN. The last closing price for Legend Biotech was US$32,78. Over the last year, Legend Biotech shares have traded in a share price range of US$ 0,00 to US$ 0,00.

Legend Biotech currently has 181.911.035 shares in issue. The market capitalisation of Legend Biotech is US$5,96 billion.

LEGN Neueste Nachrichten

Weitere Nachrichten

Form 144 - Report of proposed sale of securities

26 Dezember 2024
Edgar (US Regulatory)

Form 144 - Report of proposed sale of securities

26 Dezember 2024
Edgar (US Regulatory)

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

23 Dezember 2024
Edgar (US Regulatory)

Legend Biotech to Present at the 43rd Annual J.P. Morgan Healthcare Conference

SOMERSET, N.J., Dec. 19, 2024 (GLOBE NEWSWIRE) -- Legend Biotech Corporation (NASDAQ: LEGN) (Legend Biotech), a global leader in cell therapy, today announced that Ying Huang, Ph.D., the...

19 Dezember 2024
GlobeNewswire Inc.

CARVYKTI® Significantly Improved Minimal Residual Disease Negativity Compared to Standard of Care for Patients with Relapsed or Refractory Multiple Myeloma

89 percent of evaluable patients achieved minimal residual disease (MRD) negativity with CARVYKTI® after three-year follow-up in CARTITUDE-4 study; the majority in less than 2 monthsResults add to...

10 Dezember 2024
GlobeNewswire Inc.

Form 144 - Report of proposed sale of securities

02 Dezember 2024
Edgar (US Regulatory)

Form S-8 - Securities to be offered to employees in employee benefit plans

14 November 2024
Edgar (US Regulatory)

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

12 November 2024
Edgar (US Regulatory)

Legend Biotech Reports Third Quarter 2024 Results and Recent Highlights

CARVYKTI® (ciltacabtagene autoleucel; cilta-cel) updates: Net trade sales of approximately $286 million, representing operational growth of 87.6% year-over-year and 53.2...

12 November 2024
GlobeNewswire Inc.

Legend Biotech to Host Investor Event During the 66th American Society of Hematology (ASH) Annual Meeting and Exposition

SOMERSET, N.J., Nov. 07, 2024 (GLOBE NEWSWIRE) -- Legend Biotech Corporation (NASDAQ: LEGN) (Legend Biotech), a global leader in cell therapy, will host a live webcast event for investors on...

07 November 2024
GlobeNewswire Inc.
Zeitraum †ÄnderungÄnderung %HandelsbeginnHochNiedrigDurchsch. VolumenVWAP
10000000DR
40000000DR
120000000DR
260000000DR
520000000DR
1560000000DR
2600000000DR

LEGN - Frequently Asked Questions (FAQ)

What is the current Legend Biotech share price?
The current share price of Legend Biotech is US$ 32,54
How many Legend Biotech shares are in issue?
Legend Biotech has 181.911.035 shares in issue
What is the market cap of Legend Biotech?
The market capitalisation of Legend Biotech is USD 5,96B
What is the 1 year trading range for Legend Biotech share price?
Legend Biotech has traded in the range of US$ 0,00 to US$ 0,00 during the past year
What is the reporting currency for Legend Biotech?
Legend Biotech reports financial results in USD
What is the latest annual turnover for Legend Biotech?
The latest annual turnover of Legend Biotech is USD 285,14M
What is the latest annual profit for Legend Biotech?
The latest annual profit of Legend Biotech is USD -518,25M
What is the registered address of Legend Biotech?
The registered address for Legend Biotech is 4TH FLOOR, HARBOUR PLACE, 103 SOUTH CHURCH STREET, PO BOX 10240, GRAND CAYMAN, KY1 1002
What is the Legend Biotech website address?
The website address for Legend Biotech is www.legendbiotech.com
Which industry sector does Legend Biotech operate in?
Legend Biotech operates in the PHARMACEUTICAL PREPARATIONS sector

Beweger

Alle Anzeigen
  • Volumen
  • % Tops
  • % Flops
SymbolPreisVol.
INTZIntrusion Inc
US$ 1,87
(315,56%)
144,17M
AILEiLearningEngines Inc
US$ 0,5786
(258,27%)
490,11M
GTIGraphjet Technology
US$ 1,01
(198,38%)
323,6M
HUBCWHub Cyber Security Ltd
US$ 0,0265
(165,00%)
1,43M
LITMSnow Lake Resources Ltd
US$ 1,6894
(91,98%)
106,57M
NEUPNeuphoria Therapeutics Inc
US$ 4,01
(-92,49%)
868,74k
VIRXViracta Therapeutics Inc
US$ 0,1591
(-32,87%)
6,08M
PRFXPainReform Ltd
US$ 3,49
(-28,78%)
826,16k
AIREreAlpha Tech Corporation
US$ 2,5553
(-28,62%)
7,19M
TOIIWOncology Institute Inc
US$ 0,0072
(-23,40%)
46,66k
AILEiLearningEngines Inc
US$ 0,5786
(258,27%)
495,64M
GTIGraphjet Technology
US$ 1,01
(198,38%)
323,8M
RGTIRigetti Computing Inc
US$ 17,518
(13,46%)
238,98M
XTIAXTI Aerospace Inc
US$ 0,0399
(-0,25%)
230,23M
QSIQuantum Si Inc
US$ 3,7292
(73,45%)
199,91M

Foren

Foren anzeigen
Keine Diskussionen Gefunden.
Neuen Thread Erstellen

Kürzlich von Ihnen besucht

NASDAQ
LEGN
Legend Biotech
NASDAQ
CBBNX
Canadian Equity Value Co...
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Deutschland
Unternehmen
Geschäft
Popular
App herunterladen
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen

© 2024 ADVFN PLC - Alle Rechte vorbehalten